Remove Cooper Remove Development Remove Marketing Remove Pharmaceuticals
article thumbnail

To Innovate in a Big Company, Don’t Think “Us Against Them”

Harvard Business Review

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. As part of this effort, they discovered that the majority of employees who were advising Janssen on emerging markets had never set foot in those countries. But it does happen.

article thumbnail

You Need a Community, Not a Network

Harvard Business Review

When networks develop into communities, the results can be powerful. Look at the accomplishments of Wikipedia contributors, open-source software developers who find and fix bugs in Linux, or doctors who help each another with difficult diagnoses as part of the Sermo social network.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Meditation Benefits CEOs

Harvard Business Review

“There was this one instance where the market tanked and there was panic on the desk. Thanks to my meditation practice, I was able to keep my composure and propose solutions to reduce the impact of the market crash.” “Thanks to meditation I have developed patience.” The trading desk was an organized riot.

CEO 8
article thumbnail

Is the Cost of Innovation Falling?

Harvard Business Review

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M. In fact, the costs of developing seminal software algorithms continue to rise, too.

Cost 8
article thumbnail

Using Games to Get a Handle on Bank Risk

Harvard Business Review

Bank marketing materials focus on the dreams, anxieties and goals of consumers. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk.

Banking 10
article thumbnail

India Remakes Global Innovation

Harvard Business Review

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

article thumbnail

Here Are All the Reasons It’s a Bad Idea to Let a Few Tech Companies Monopolize Our Data

Harvard Business Review

Facebook, at that time, allowed app developers to collect this personal data. ” By that I mean companies that control a key platform which, like a coral reef, attracts to its ecosystem users, sellers, advertisers, software developers, apps, and accessory makers. But this was not the first time its policies were violated.